Whether you are a new T1D Family, a TrialNet participant, a healthcare provider, or a researcher — you'll find resources here.
We’re here to help you after a new T1D diagnosis. Get answers to frequently asked questions and learn about clinical studies testing ways to maintain insulin production.
While you wait for screening results, get answers to your questions, find out about next steps, and learn more about TrialNet’s Pathway to Prevention.
Your T1D families are important to you. Learn how easy it is to connect your patients with world-class T1D research.
TrialNet offers a unique screening test for relatives of people with T1D that can detect the disease at its earliest stage. We look for autoantibodies that signal an increased risk of T1D years before symptoms appear.
The JDRF, ADA and Endocrine Society now classify having two or more of these autoantibodies as early stage T1D. Research shows that almost all individuals who have two or more of these autoantibodies will develop T1D.
Those at increased risk may be eligible to take part in clinical studies to change the course of the disease. There’s no cost to you or your patients.
Here’s how you can help
Inform your patients about the availability and importance of risk screening—now listed as a standard of care by the American Diabetes Association (2017 ADA Standards of Medical Care in Diabetes). Contact firstname.lastname@example.org to order patient resources or contact us at 800-425-8361.
Arrange for a screening event. Just select the location and date. We’ll assist you with logistics and promotion, provide screening test kits, cover any associated costs, and even provide a phlebotomist, if needed.